258 related articles for article (PubMed ID: 29447437)
1. J-Shaped Association Between Postoperative Levothyroxine Dosage and Fracture Risk in Thyroid Cancer Patients: A Retrospective Cohort Study.
Shin DW; Suh B; Lim H; Yun JM; Song SO; Park Y
J Bone Miner Res; 2018 Jun; 33(6):1037-1043. PubMed ID: 29447437
[TBL] [Abstract][Full Text] [Related]
2. Increased Risk of Type 2 Diabetes in Patients With Thyroid Cancer After Thyroidectomy: A Nationwide Cohort Study.
Roh E; Noh E; Hwang SY; Kim JA; Song E; Park M; Choi KM; Baik SH; Cho GJ; Yoo HJ
J Clin Endocrinol Metab; 2022 Feb; 107(3):e1047-e1056. PubMed ID: 34718625
[TBL] [Abstract][Full Text] [Related]
3. Increased cardiovascular risk in thyroid cancer patients taking levothyroxine: a nationwide cohort study in Korea.
Suh B; Shin DW; Park Y; Lim H; Yun JM; Song SO; Park JH; Cho B; Guallar E
Eur J Endocrinol; 2019 Jan; 180(1):11-20. PubMed ID: 30400044
[TBL] [Abstract][Full Text] [Related]
4. Risk of Subsequent Primary Cancers in Thyroid Cancer Survivors according to the Dose of Levothyroxine: A Nationwide Cohort Study.
Kim MS; Lee JW; Hyun MK; Song YS
Endocrinol Metab (Seoul); 2024 Apr; 39(2):288-299. PubMed ID: 38437824
[TBL] [Abstract][Full Text] [Related]
5. Ten-year estimated risk of bone fracture in women with differentiated thyroid cancer under TSH-suppressive levothyroxine therapy.
Vera L; Gay S; Campomenosi C; Paolino S; Pera G; Monti E; Mortara L; Seriolo B; Giusti M
Endokrynol Pol; 2016; 67(4):350-8. PubMed ID: 27387240
[TBL] [Abstract][Full Text] [Related]
6. Risk of Fractures in Thyroid Cancer Patients With Postoperative Hypoparathyroidism: A Nationwide Cohort Study in Korea.
Ahn SH; Lee YJ; Hong S; Park JW; Jeon YJ; Yoo BN; Ha YC; Bak JK; Kim HY; Lee YK
J Bone Miner Res; 2023 Sep; 38(9):1268-1277. PubMed ID: 37338940
[TBL] [Abstract][Full Text] [Related]
7. Risk of osteoporosis in thyroid cancer patients using levothyroxine: a population-based study.
Lin SY; Lin CL; Chen HT; Kao CH
Curr Med Res Opin; 2018 May; 34(5):805-812. PubMed ID: 28884595
[TBL] [Abstract][Full Text] [Related]
8. Levothyroxine treatment and occurrence of fracture of the hip.
Sheppard MC; Holder R; Franklyn JA
Arch Intern Med; 2002 Feb; 162(3):338-43. PubMed ID: 11822927
[TBL] [Abstract][Full Text] [Related]
9. Increased Risk of Osteoporotic Fracture in Postgastrectomy Gastric Cancer Survivors Compared With Matched Controls: A Nationwide Cohort Study in Korea.
Shin DW; Suh B; Lim H; Suh YS; Choi YJ; Jeong SM; Yun JM; Song SO; Park Y
Am J Gastroenterol; 2019 Nov; 114(11):1735-1743. PubMed ID: 31658122
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing TSH suppression efficacy in postoperative papillary thyroid carcinoma patients: a retrospective cohort study.
Zhang Q; Zhong ZZ; Wu T; He YQ
BMC Surg; 2024 May; 24(1):133. PubMed ID: 38702652
[TBL] [Abstract][Full Text] [Related]
11. Levothyroxine dose and fracture risk according to the osteoporosis status in elderly women.
Ko YJ; Kim JY; Lee J; Song HJ; Kim JY; Choi NK; Park BJ
J Prev Med Public Health; 2014 Jan; 47(1):36-46. PubMed ID: 24570805
[TBL] [Abstract][Full Text] [Related]
12. Association of Thyrotropin Suppression With Survival Outcomes in Patients With Intermediate- and High-Risk Differentiated Thyroid Cancer.
Klubo-Gwiezdzinska J; Auh S; Gershengorn M; Daley B; Bikas A; Burman K; Wartofsky L; Urken M; Dewey E; Smallridge R; Chindris AM; Kebebew E
JAMA Netw Open; 2019 Feb; 2(2):e187754. PubMed ID: 30707227
[TBL] [Abstract][Full Text] [Related]
13. Association of Female Reproductive Factors With Incidence of Fracture Among Postmenopausal Women in Korea.
Yoo JE; Shin DW; Han K; Kim D; Yoon JW; Lee DY
JAMA Netw Open; 2021 Jan; 4(1):e2030405. PubMed ID: 33404618
[TBL] [Abstract][Full Text] [Related]
14. Incidence and risk factors of subsequent osteoporotic fracture: a nationwide cohort study in South Korea.
Shim YB; Park JA; Nam JH; Hong SH; Kim JW; Jeong J; Shin JY
Arch Osteoporos; 2020 Nov; 15(1):180. PubMed ID: 33188505
[TBL] [Abstract][Full Text] [Related]
15. Bone mineral density in women receiving thyroxine suppressive therapy for differentiated thyroid carcinoma.
Chen CH; Chen JF; Yang BY; Liu RT; Tung SC; Chien WY; Lu YC; Kuo MC; Hsieh CJ; Wang PW
J Formos Med Assoc; 2004 Jun; 103(6):442-7. PubMed ID: 15278189
[TBL] [Abstract][Full Text] [Related]
16. Long-term use of dipeptidyl peptidase-4 inhibitors and risk of fracture: A retrospective population-based cohort study.
Driessen JH; van den Bergh JP; van Onzenoort HA; Henry RM; Leufkens HG; de Vries F
Diabetes Obes Metab; 2017 Mar; 19(3):421-428. PubMed ID: 27943565
[TBL] [Abstract][Full Text] [Related]
17. Is Partial or Total Thyroidectomy Associated with Risk of Long-Term Osteoporosis: A Nationwide Population-Based Study.
Hung CL; Yeh CC; Sung PS; Hung CJ; Muo CH; Sung FC; Jou IM; Tsai KJ
World J Surg; 2018 Sep; 42(9):2864-2871. PubMed ID: 29541822
[TBL] [Abstract][Full Text] [Related]
18. Prediction of thyroid hormone supplementation after thyroid lobectomy.
Lee DY; Seok J; Jeong WJ; Ahn SH
J Surg Res; 2015 Jan; 193(1):273-8. PubMed ID: 25088372
[TBL] [Abstract][Full Text] [Related]
19. Bone mineral density and bone fracture in male patients receiving long-term suppressive levothyroxine treatment for differentiated thyroid carcinoma.
Reverter JL; Colomé E; Holgado S; Aguilera E; Soldevila B; Mateo L; Sanmartí A
Endocrine; 2010 Jun; 37(3):467-72. PubMed ID: 20960170
[TBL] [Abstract][Full Text] [Related]
20. The excess risk of major osteoporotic fractures in hypothyroidism is driven by cumulative hyperthyroid as opposed to hypothyroid time: an observational register-based time-resolved cohort analysis.
Abrahamsen B; Jørgensen HL; Laulund AS; Nybo M; Bauer DC; Brix TH; Hegedüs L
J Bone Miner Res; 2015 May; 30(5):898-905. PubMed ID: 25431028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]